Bausch + Lomb Corporation has announced the publication of results from a phase 3 study on LUMIFY® Preservative Free Redness Reliever Eye Drops in the journal Ophthalmology and Therapy. The study evaluated the efficacy and safety of the preservative-free formulation compared to the original LUMIFY eye drops in reducing ocular redness. Conducted with 380 participants, the trial demonstrated that LUMIFY Preservative Free is statistically non-inferior to LUMIFY in reducing redness, with a similar safety profile. The results suggest LUMIFY Preservative Free as a well-tolerated option for individuals with sensitivities to preservatives. Additional information is available on the LUMIFY website.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bausch + Lomb Corp. published the original content used to generate this news brief via Business Wire (Ref. ID: 20250729847370) on July 29, 2025, and is solely responsible for the information contained therein.